Panacea Life Sciences Holdings, Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Panacea Life Sciences Holdings, Inc. (PLSH) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $0.21 per share for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2024-04-01
- Panacea Life Sciences Holdings, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2021-03-31 was $0.03, a 91.67% decline year-over-year.
- Panacea Life Sciences Holdings, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2020-03-31 was $0.30, a 57.89% increase year-over-year.
- Panacea Life Sciences Holdings, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2019-03-31 was $0.19.
- Panacea Life Sciences Holdings, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2023 was $0.21.
- Panacea Life Sciences Holdings, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2020 was $0.30, a 42.86% increase from fiscal 2019.
- Panacea Life Sciences Holdings, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2019 was $0.21, a 48.78% decline from fiscal 2018.
- Panacea Life Sciences Holdings, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2018 was $0.41.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.21 10-K · filed 2024-04-01 | |||
| 2023-09-30 | $0.21 10-Q · filed 2023-11-14 | |||
| 2023-06-30 | $0.21 10-Q · filed 2023-08-15 | |||
| 2021-06-30 | $0.03 10-Q · filed 2021-08-23 | |||
| 2021-03-31 | $0.03 10-Q/A · filed 2021-05-27 | |||
| 2020-12-31 | $0.30 10-K/A · filed 2021-04-23 | |||
| 2020-09-30 | $0.30 10-Q · filed 2020-11-18 | |||
| 2020-06-30 | $0.30 10-Q · filed 2020-08-19 | |||
| 2020-03-31 | $0.30 10-Q · filed 2020-06-29 | |||
| 2019-12-31 | $0.21 10-K/A · filed 2021-04-23 | |||
| 2019-09-30 | $0.21 10-Q · filed 2019-11-14 | |||
| 2019-06-30 | $0.19 10-Q · filed 2019-08-14 | |||
| 2019-03-31 | $0.19 10-Q · filed 2019-05-20 | |||
| 2018-12-31 | $0.41 10-K · filed 2020-05-22 | |||
| 2018-09-30 | $0.09 10-Q · filed 2018-11-14 |